Firms

Avego Healthcare Capital

Avego Healthcare Capital

avego.com

Avego Healthcare Capital is Avego's private equity strategy for commercial-stage healthcare businesses. It invests in specialty pharmaceuticals, pharmaceutical services, life sciences tools, over-the-counter products and medical devices, combining growth capital with operating experience and company-building support. The strategy shares the Avego group's offices in Alpharetta, Georgia, and New York. Its Fund II was formed in 2022; SEC disclosures identify Bala Venkataraman as manager of the general partner, James Flexner and Thomas Vandervort as managing partners, Kevin McNeill as partner and Alyssa Romano as fund CFO. All five remain listed in Avego's public group team directory. In November 2025, Avego Healthcare Capital Fund II invested EUR25 million in myTomorrows, an AI-enabled treatment-access platform. This private equity strategy is distinct from Avego BioScience Capital's therapeutics venture strategy and Velan Capital's public equities strategy.

Founded
—
Type
Venture capital

Funds1

  • Avego Healthcare Capital Fund II, L.P.—

    Avego Healthcare Capital's second private equity fund, formed in Delaware in 2022. The general partner is Avego Healthcare Capital GP II, LLC. An October 12, 2023 SEC amendment reported USD278,050,000 of interests sold in an indefinite offering. This is a dated fundraising snapshot, with no final fund size or close inferred. Transaction counsel identifies this fund as the investor in myTomorrows' November 2025 EUR25 million growth equity financing.

Team

Operations and support

Alyssa RomanoAlyssa RomanoChief Financial Officer of Fund II
Bala VenkataramanBala VenkataramanManager of the General Partner
James FlexnerJames FlexnerManaging Partner of the General Partner
Kevin McNeillKevin McNeillPartner of the General Partner
Thomas VandervortThomas VandervortManaging Partner of the General Partner

Co-investing

No co-investors on record yet.

Investments